지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수8
목 차표 목차 ···················································ⅲ그림 목차 ·················································ⅳ국문 초록 ·················································ⅴⅠ. 서론 ···················································11. 연구 필요성 ···········································12. 연구 목적 ·············································4Ⅱ. 연구대상 및 방법 ·······································51. 연구대상 ··············································52. 연구방법 ··············································71) 설문조사·············································72) 구강검사·············································83) 임플란트주위염 관련 병원성 미생물 정량분석············103. 연구절차 ···············································134. 통계분석 ···············································15Ⅲ. 연구결과 ···············································161. 임플란트 치주낭 내 병원성 미생물 출현율과 양···········162. 임플란트 치주낭 내 병원성 미생물 간 상관관계···········193. 건강상태와 임플란트 치주낭 내 병원성 미생물 양·········211) 당뇨 및 고혈압에 따른 임플란트 치주낭 내 병원성 미생물 양·212) 치주낭보유분악 수에 따른 임플란트 치주낭 내 병원성 미생물 양·234. 건강 행위와 임플란트 치주낭 내 병원성 미생물 양········251) 흡연 여부에 따른 임플란트 치주낭 내 병원성 미생물 양·252) 음주 여부에 따른 임플란트 치주낭 내 병원성 미생물 양·273) 치주관리에 따른 임플란트 치주낭 내 병원성 미생물 양· 284) 치면세균막 관리능력에 따른 임플란트 치주낭 내 병원성 미생물 양· 30Ⅳ. 고찰 ···················································32Ⅴ. 결론 ···················································39Ⅵ. 참고문헌 ···············································41부록. 설문지 ···············································50Abstract ···················································52표 목 차표 1.연구대상자의 특성································6표 2.사용된 균주······································11표 3.임플란트 치주낭 내 병원성 미생물 출현율과 양·····18표 4.임플란트 치주낭 내 병원성 미생물의 상관관계······20표 5.당뇨 및 고혈압에 따른 임플란트 치주낭 내 병원성 미생물 양 22표 6.치주낭보유분악수에 따른 임플란트 치주낭 내 병원성 미생물 양24표 7.흡연 여부에 따른 임플란트 치주낭 내 병원성 미생물 양26표 8.음주 여부에 따른 임플란트 치주낭 내 병원성 미생물 양27표 9.치주관리에 따른 임플란트 치주낭 내 병원성 미생물 양29표 10.치면세균막 관리능력에 따른 임플란트 치주낭 내 병원성 미생물 양·····································31그 림 목 차그림 1. Amplication of profiles for C.rectus-specific PCR products 12그림 2.Standard curve of C. rectus··························· 12그림 3.연구절차·············································14그림 4.연구대상자의 11가지 병원성 미생물의 출현율(%)·······17
0